18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
NCT04647214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2025-08-03
Summary
Study to collect effectiveness and safety data after administration of a bimatoprost intracameral implant in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Conditions
- Open-angle Glaucoma
- Ocular Hypertension
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
ALLERGAN INC. · Allergan
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-03
- Primary Completion
- 2024-07-12
- Completion
- 2024-07-12
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
NCT02247804 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT01830140 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
NCT02537015 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dose-Ranging Study of the Bimatoprost Ocular Insert
NCT02358369 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution
NCT01001195 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
NCT02143843 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00538304 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01099774 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
NCT00716742 ·Status: COMPLETED
-
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02061683 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT04285580 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
NCT03850782 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02636946 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of a Drug Delivery System in Glaucoma
NCT01016691 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Bimatoprost 0.01% in the Clinical Setting
NCT01814761 ·Status: COMPLETED
-
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
NCT01594970 ·Status: COMPLETED ·Phase: PHASE4
-
Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
NCT00487214 ·Status: COMPLETED
-
A Study of LUMIGAN® RC in the Clinical Setting
NCT01833741 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
NCT02742649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
NCT00541242 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01110499 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
NCT00652496 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT05335122 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02020512 ·Status: COMPLETED ·Phase: PHASE4